FDA approves Eli Lilly weight loss pill
Quick Insights
The Bottom Line
The FDA approved Eli Lilly's new GLP-1 weight loss drug, expanding obesity treatment options.
How This Affects You
Patients may gain access to another weight loss medication; cost and insurance coverage will determine affordability for individuals seeking obesity treatment.
AI Summary
The FDA approved a new GLP-1 weight loss medication from Eli Lilly, expanding the pharmaceutical options available for obesity treatment. GLP-1 drugs mimic a hormone that regulates appetite and blood sugar, and have become increasingly popular for weight management in recent years. Eli Lilly's entry into this market intensifies competition with existing GLP-1 therapies like Ozempic and Wegovy, which have experienced supply constraints and high demand. The approval gives patients and physicians another treatment choice, though questions remain about long-term efficacy, cost, and insurance coverage. This move underscores the growing commercial opportunity in obesity treatment as the drugs gain wider adoption.
Source Coverage Map
6 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthUS approves new oral weight-loss pill developed by Eli Lilly
<p>Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy</p><p>The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.</p><p>Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received <a href="https://www.theguardian.com/us-news/2025/dec/22/us-regulators-approve-wegovy-weight-loss-pill">approval</a> in December.</p> <a href="https://www.theguardian.com/us-news/2026/apr/01/new-weight-loss-pill-glp-1-foundayo">Continue reading...</a>
HealthFDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.
CorporateInsilico Medicine secures $2.75 billion drug collaboration with Eli Lilly - Reuters
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQRUtWbXlUNS04X1dualdiUTg0ME11ajdLb3FGekwyT1lXbFhmT2ltNUVUUVFna1RQYmh6OUJRcWd5bk1ETXE0LUNWbVRRU0NQUFFYaWk4bXlwX3EwX1lSTW1WWHFsV2c3R0ZpT1p6S29fMDlBdzhtRy1VY1VoV1hDaGg3UnJzNDlkSGVTeE5HckNCUmxBNUZxN3dhRm1FT2ltaE43UDVQUUMtQTZIdkRPV1dreGVXOEljMEdoVlNZXzd4Z2N3RXdUWkFZdnVtUEFpRHlXaWtMZ092ajV6MDNr?oc=5" target="_blank">Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly</a> <font color="#6f6f6f">Reuters</font>
HealthNew heart health dietary guidelines
The American Heart Association has released new dietary guidelines on how to stay heart healthy to improve quality of life and save lives. Dr. Celine Gounder breaks down what to know.
HealthCeline Dion announces first concerts since stiff-person syndrome diagnosis with Paris residency - AP News
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNTmZ3RmpKanhzZzhhRXBvbzFHdjF0SnItcWM3Y0d1aHhhd2xfZG0wVmZieC1fZ3VlZXRucGpFakhvcGVETUtfQXczOFZOMlBPOXhNcnhVSXYxdGh6QjNyRlNfRFBsbUJKY21OVzl0T3dqR09idE1KWmRld0JudlQ1Ti1FX0VXR0pLY3g0ZVlrRkQ?oc=5" target="_blank">Celine Dion announces first concerts since stiff-person syndrome diagnosis with Paris residency</a> <font color="#6f6f6f">AP News</font>
Civil RightsThe Women Who Believe Women Should Lose the Right to Vote - The New York Times
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE55UE1VQ2NIOFhsa0N6eDM0RDhnMUFIZGt5U0xpTDJmWkdvRWY4dWtDZkdiQS1BZzd6MEh4bmt3Y25zZ3hxWGotVnI1cnJPTVhNaDlmVmotN2piTnhxWHZteGJLMWVlMVYyRWc4Y3VCMXg?oc=5" target="_blank">Supporters of Household Voting Believe U.S. Would Be Better Off Without Women’s Vote</a> <font color="#6f6f6f">The New York Times</font>
Hundreds of hospitals threatened by Medicaid cuts: Research
More than 400 hospitals across the country are in danger of closing or reducing services because of cuts to Medicaid funding under the GOP’s massive reconciliation package last year, according to new research. A report from Public Citizen found that 446 hospitals — 267 in urban areas and 176 in rural areas — are at…
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
'The gravest crime against humanity': What does the UN vote on slavery mean?
After 16 years and $8 billion, the military's new GPS software still doesn't work
US paves way for private assets to be included in 401(k) retirement plans - Reuters
US votes against UN resolution labeling slavery ‘gravest crime against humanity’
White House AI rollout exposes widening rift
